GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Vertex Pharmaceuticals Incorporated (VRTX) [hlAlert]

Vertex Pharmaceuticals Inc. discovers, develops and markets small molecule drugs that address major unmet medical needs. The company has eight drug candidates in
clinical development to treat viral diseases, inflammation, cancer, autoimmune diseases and neurological disorders. Vertex has created its pipeline using a proprietary information-based approach to drug design that integrates multiple technologies in biology, chemistry and biophysics aimed at increasing the speed and success rate of drug discovery. (PRESS RELEASE).
( Total: 44 Current Stock Recommendations )
Vertex Pharmaceuticals Incorporated   (44)
Sell Hold 36% Buy 59%
Related companies
Forest ...   (37)
Sell Hold 51% Buy 43%
Perrigo Company   (24)
Hold 29% Buy 71%
Valeant ...   (27)
Sell 15% Hold 26% Buy 59%
Allergan Plc   (28)
Hold 29% Buy 71%
Biogen Idec Inc   (41)
Sell Hold 27% Buy 68%
Biomarin ...   (35)
Hold 37% Buy 63%
Mylan Laboratories, ...   (21)
Hold 29% Buy 71%
Cardinal Health, ...   (24)
Hold 29% Buy 71%
Incyte Corporation   (22)
Sell Hold Buy 82%
Salix ...   (31)
Hold 39% Buy 61%
Show  

Date (ET)MemberRatingYTD
Gains
 
7/25/2007  
Buy
  
9/28/2007  
Buy
  
11/5/2007  
Hold
  
1/16/2008  
Buy
  
1/24/2008  
Hold
  
3/12/2008  
Hold
  
3/31/2008  
Buy
  
4/1/2008  
Hold
  
4/25/2008  
Buy
  
4/28/2008  
Hold
  
6/5/2008  
Buy
  
10/30/2008  
Buy
  
10/30/2009  
Buy
  
11/17/2009  
Hold
  
1/5/2010  
Sell
  
1/5/2010  
Sell
  
4/12/2010  
Hold
  
5/26/2010  
Buy
  
2/24/2011  
Buy
  
5/4/2011  
Hold
  
5/5/2011  
Buy
  
10/4/2011  
Buy
  
2/1/2012  
Buy
  
7/31/2012  
Hold
  
8/30/2012  
Buy
  
11/12/2012  
Hold
  
1/15/2013  
Hold
  
2/7/2013  
Buy
  
4/19/2013  
Hold
  
4/19/2013  
Buy
  
8/22/2013  
Buy
  
10/30/2013  
Hold
  
11/1/2013  
Hold
  
6/25/2014  
Buy
  
11/6/2014  
Buy
  
1/29/2015  
Hold
  
1/29/2015  
Hold
  
1/29/2015  
Buy
  
4/10/2015  
Buy
  
6/23/2015  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy